Publikationen
Rauch, L., Hein, R., Biedermann, T., Eyerich, K., Lauffer, F. Bisphosphonates for the treatment of calcinosis cutis—a retrospective single-center study. Biomedicines. 2021 Nov 16.
Philipp Speth*, Manja Jargosch*, Peter Seiringer, Kristina Schwamborn, Tanja Bauer, Cora Scheerer, Ulrike Protzer, Carsten Schmidt-Weber, Tilo Biedermann, Stefanie Eyerich, Natalie Garzorz-Stark. Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection. J Invest Dermatol. 2021 Sep 1.
Garzorz-Stark, N., Beicht, S., Baghin, V., Biedermann, T., Lauffer, F. IMPROVE 1.0: Individual Monitoring of Psoriasis Activity by Regular Online App Questionnaires and Outpatient Visits. Frontiers in Medicine. 2021 Jun 22.
Lauffer F*, Baghin V*, Standl M, Stark SP, Jargosch M, Wehrle J, Thomas J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K, Garzorz-Stark N. Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins. Allergy. 2020 Sep 1.
Lauffer F*, Jargosch M*, Baghin V, Krause L, Kempf W, Absmaier-Kijak M, Morelli M, Madonna S, Marsais F, Lepescheux L, Albanesi C, Müller NS, Theis FJ, Schmidt-Weber C, Eyerich S, Biedermann T, Vandeghinste N, Steidl S, Eyerich K. IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):800-809. doi: 10.1111/jdv.16126. Epub 2020 Jan 19.
Lauffer F*, Jargosch M*, Baghin V, Krause L, Kempf W, Absmaier-Kijak M, Morelli M, Madonna S, Marsais F, Lepescheux L, Albanesi C, Mueller NS, Theis FJ, Schmidt-Weber C, Eyerich S, Biedermann T, Vandeghinste N, Steidl S, Eyerich K
IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema
J Eur Acad Dermatol Venereol. 2019 Nov
Lauffer F, Jargosch M, Krause L, Garzorz-Stark N, Franz R, Roenneberg S, Böhner A, Mueller NS, Theis FJ, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis. J Invest Dermatol. 2018 Mar 8.
Garzorz-Stark N*, Lauffer F*, Krause L, Thomas J, Altenhan A, Franz R, Roenneberg S, Boehner A, Jargosch M, Batra R, Mueller NS, Haak S, Gross C, Gross O, Traidl-Hoffmann C, Theis FJ, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. TLR7/8 agonists stimulate plasmacytoid dendritic cells to initiate a Th17-deviated acute contact dermatitis in humans. J Allergy Clin Immunol 2018 Apr.
Vandeghinste N, Klattig J, Jagerschmidt C, Lavazais S, Marsais F, Haas JD, Auberval M, Lauffer F, Moran T, Ongenaert M, Van Balen M, Dupont S, Lepescheux L, Garcia T, Härtle S, Eyerich K, Fallon PG, Brys R, Steidl S.Neutralization of IL-17C reduces skin inflammation in mouse models of psoriasis and atopic dermatitis. J Invest Dermatol. 2018 Feb
Zink A, Herrmann M, Fischer T, Lauffer F, Garzorz-Stark N, Böhner A, Spinner CD, Biedermann T, Eyerich K. Addiction: an underestimated problem in psoriasis healthcare. J Eur Acad Dermatol Venereol. 2017 Mar
Lauffer F, Ring J.
Target-oriented therapy: Emerging drugs for atopic dermatitis
Expert Opin Emerg Drugs. 2016 Mar
Garzorz N, Krause L, Lauffer F, Attenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. A novel molecular disease classifier for psoriasis and eczema. Ep Dermatol 2016; May 19
Garzorz N, Alsisi M, Todorova A, Atenhan A, Thomas J, Lauffer F, Ring J, Schmidt-Weber C, Biedermann T, Eyerich S, Eyerich K Dissecting susceptibility from exogenous triggers: The model of alopecia areata and associated inflammatory skin diseases J Eur Acad Dermatol Venereol 2015